Published in
Elsevier, Seminars in Arthritis and Rheumatism, (58), p. 152149, 2023
DOI: 10.1016/j.semarthrit.2022.152149
Links
Tools
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)
Journal article published in 2023 by
Namrata Singh 
,
Vithal Madhira ,
Chen Hu,
Amy L. Olex,
Timothy Bergquist,
Kathryn C. Fitzgerald,
Jared D. Huling,
Rena C. Patel,
Jasvinder A. Singh
,
Vithal Madhira ,
Chen Hu,
Amy L. Olex,
Timothy Bergquist,
Kathryn C. Fitzgerald,
Jared D. Huling,
Rena C. Patel,
Jasvinder A. Singh
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 